SK-NK Cell Injection Clinical Trials

1 actively recruiting trial

Also known as: Allogeneic NK Cell Injection, Super Kill-NK Cell Injection

Pipeline

Phase 1/2: 1

Top Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences1

Indications

Ovarian Neoplasms Malignant1
Ascites1
Cancer1

Other1 trial

Intraperitoneal SK-NK Cell Injection for Advanced Ovarian Cancer With Massive Ascites

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.